ALKS vs EG · P/E 14, rev $1.56B vs P/E 17, rev $17.28B
Alkermes Plc (ALKS) versus Everest Group Ltd (EG) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Everest Group Ltd (EG) is a insurance - reinsurance company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported EG revenue for 2024-12-31 was $17.28B. Net income was $1.37B. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. EG currently screens at market cap $14.52B and trailing P/E 17.2.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. EG currently screens at market cap $14.52B and trailing P/E 17.2.
Not investment advice. Open the ALKS and EG stock pages for the full models.
Not investment advice.